Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Nov 28, 2016 $89.00 $89.10 $87.01 $88.36 1 368 432
Nov 25, 2016 $88.06 $89.10 $86.52 $89.00 647 620
Nov 23, 2016 $84.59 $88.39 $83.62 $88.10 1 299 103
Nov 22, 2016 $87.51 $88.30 $84.42 $85.43 1 047 011
Nov 21, 2016 $89.13 $89.99 $86.74 $87.50 1 132 414
Nov 18, 2016 $90.42 $91.21 $88.92 $89.00 824 650
Nov 17, 2016 $89.15 $92.30 $88.70 $90.74 1 114 066
Nov 16, 2016 $91.61 $92.31 $89.31 $89.39 912 945
Nov 15, 2016 $91.93 $92.65 $89.39 $92.21 1 167 121
Nov 14, 2016 $91.78 $93.85 $90.13 $92.91 1 620 357
Nov 11, 2016 $93.28 $93.28 $90.11 $91.46 1 243 367
Nov 10, 2016 $92.80 $95.56 $91.46 $93.54 2 162 093
Nov 09, 2016 $89.00 $98.34 $88.52 $91.83 3 867 259
Nov 08, 2016 $82.79 $84.46 $82.12 $83.43 1 240 163
Nov 07, 2016 $82.64 $84.07 $81.64 $83.54 1 876 800
Nov 04, 2016 $79.65 $84.59 $78.75 $82.00 2 088 500
Nov 03, 2016 $81.43 $81.43 $78.42 $78.62 1 471 800
Nov 02, 2016 $82.38 $82.71 $80.77 $80.90 1 223 700
Nov 01, 2016 $80.30 $82.88 $79.31 $82.71 1 182 100
Oct 31, 2016 $81.26 $81.26 $80.00 $80.52 1 125 300
Oct 28, 2016 $79.73 $83.32 $78.56 $81.13 1 921 800
Oct 27, 2016 $82.29 $83.39 $80.30 $81.02 1 291 900
Oct 26, 2016 $81.26 $82.60 $81.00 $81.75 951 300
Oct 25, 2016 $82.28 $82.28 $80.54 $80.96 779 700
Oct 24, 2016 $82.67 $82.89 $81.44 $82.14 892 200
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT